6 episodes

This audio podcast reports on some of the most important new MS research presented at the ECTRIMS annual meeting, held October 13-16, 2010, in Gothenburg, Sweden. Listen as James D. Bowen, MD, talks about new findings that enhance understanding of MS pathophysiology, testing, neuroregeneration, and cognition. Fred D. Lublin, MD, reviews presentations on emerging and current MS therapies.

Highlights of the European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting Projects In Knowledge, Inc

    • Science

This audio podcast reports on some of the most important new MS research presented at the ECTRIMS annual meeting, held October 13-16, 2010, in Gothenburg, Sweden. Listen as James D. Bowen, MD, talks about new findings that enhance understanding of MS pathophysiology, testing, neuroregeneration, and cognition. Fred D. Lublin, MD, reviews presentations on emerging and current MS therapies.

    Update on Current MS Therapies - Part 2

    Update on Current MS Therapies - Part 2

    Dr. Lublin discusses new data on other existing MS therapies: interferon beta, natalizumab, mitoxantrone, and fampridine.

    • 8 min
    Update on Current MS Therapies - Part 1

    Update on Current MS Therapies - Part 1

    Dr. Lublin discusses new data on existing MS therapies: glatiramer acetate and fingolimod, as well as the addition of statins to interferon beta-1a.

    • 6 min
    Update on Emerging MS Therapies - Part 2

    Update on Emerging MS Therapies - Part 2

    Dr. Lublin describes the latest data presented at ECTRIMS on additional emerging MS therapies (firategrast, cladribine, alemtuzumab, daclizumab, laquinimod, BG00012).

    • 9 min
    Update on Emerging MS Therapies - Part 1

    Update on Emerging MS Therapies - Part 1

    Dr. Lublin describes the latest data on some of the emerging MS therapies now in late-stage clinical trials (teriflunomide, ocrelizumab and ofatumumab), presented on ECTRIMS.

    • 8 min
    Testing, Neuroregeneration, and Cognition

    Testing, Neuroregeneration, and Cognition

    In this next section of the podcast, Dr. Bowen looks at the extent to which new data at ECTRIMS answer some important questions about MS testing, neuroregeneration, and cognitive impairment.

    • 12 min
    MS Pathophysiology: Immunology and Genetics

    MS Pathophysiology: Immunology and Genetics

    Dr. Bowen discusses ECTRIMS presentations on lesser-known components of the immune system that contribute to the disease. He also discusses data on genetic causes of MS.

    • 12 min

More by Projects In Knowledge, Inc